Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women

Nutrition Research

Volumn 29, Issue 9, 2009, Pages 609-615

  Maki, Kevin C ^a,b   Reeves, Mathew S ^a,b   Farmer, Mildred ^c   Griinari, Mikko ^d   Berge, Kjetil ^e   Vik, Hogne ^e   Hubacher, Rachel ^a,b   Rains, Tia M ^a,b  

^a Provident Clinical Research   (United States)

^b Provident Clinical Research   (United States)

^c Meridien Research   (United States)

^d Clanet Ltd   (Finland)

^e former employee of Aker BioMarine Antarctic AS   (Norway)

Author keywords

Bioavailability; Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Euphausiacea krill; Humans

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; KRILL OIL; MENHADEN OIL; OIL; OLIVE OIL; PLACEBO; SUPERBA KRILL OIL; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; ARTICLE; BLOATING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EUPHAUSIACEA; FATTY ACID BLOOD LEVEL; FEMALE; FLATULENCE; HAND EDEMA; HUMAN; HYPERGLYCEMIA; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OBESITY; PARALLEL DESIGN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SHRIMP; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; BLOOD UREA NITROGEN; DIETARY FATS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; EUPHAUSIACEA; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PLANT OILS;

CRUSTACEA; EUPHAUSIA SUPERBA; EUPHAUSIACEA;

EID: 70350088425     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.09.004     Document Type: Article

References (29)

1. Eslick G.D., Howe P.R., Smith C., Priest R., and Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol 136 (2009) 4-16
2. Hu F.B., Manson J.E., and Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 20 (2001) 5-19
3. Kris-Etherton P.M., Harris W.S., Appel L.J., and for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
4. Harris W.S., Kris-Etherton P.M., and Harris K.A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 10 (2008) 503-509
5. GISSI Investigators. Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
6. Breslow J. N-3 fatty acids and cardiovascular disease. Am J Clin Nutr 83 suppl (2006) 1477S-1482S
7. Leaf A., Xiao Y.F., Kang J.X., et al. Prevention of sudden cardiac death by ω-3 polyunsaturated fatty acids. Pharmacol Ther 98 (2003) 355-377
8. Davidson M.H., Stein E.A., Bays H.E., et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 29 (2007) 1354-1367
9. Maki K.C., McKenney J.M., Reeves M.S., Lubin B.C., and Dicklin M.R. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Am J Cardiol 102 (2008) 429-433
10. Harris W.S., Zucker M.L., and Dujovne C.A. Omega-3 fatty acids in hypertriglyceridemic patients: triglycerides vs methyl esters. Am J Clin Nutr 48 (1988) 992-997
11. Mozaffarian D., Lemaitre R., Kuller L., Burke G., Tracy R., and Siscovick D. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107 (2003) 1372-1377
12. Buemann B., Toubro S., Raben A., and Astruo A. Human tolerance to a single, high dose of d-tagatose. Regul Toxicol Pharmacol 29 (1999) S66-S70
13. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
15. American Oil Chemist Society. Fatty acid composition by GLC: marine oils. Method Ce 1b-89. Official Methods and Recommended Practices of the American Oil Chemist Society, 5th ed (1998), AOCS Press, Champaign, IL
16. Nyyssönen K., Kaikkonen J., and Salonen J.T. Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma. Scand J Clin Lab Invest 56 (1996) 681-689
17. Walter M.F., Blumberg J.B., Dolnikowski G.G., and Handelman G.J. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 280 (2000) 73-79
18. Harris W.S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30 (1989) 785-807
19. Harris W.S. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65 (1997) 1645S-1654S
20. Fekete K., Marosvolgyi T., Jakobik V., and Decsi T. Methods of assessment of n-3 long chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89 (2009) 2070S-2084S
21. Geleijnse J.M., Giltay E.J., Grobbee D.E., Donders A.R., and Kok F.J. Blood pressure response to fish oil supplementation: meta-regression analysis of randomized trials. J Hypertens 20 (2002) 1493-1499
22. Jacobson T.A. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 87 (2008) 1981S-1990S
23. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36 (2001) 1007-1024
24. Madsen T., Christensen J.H., Blom M., and Schmidt E.B. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 894 (2003) 517-522
25. Geelen A., Brouwer I.A., Schouten E.G., Kluft C., Katan M.B., and Zock P.L. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr 58 (2004) 1440-1442
26. Davidson M.H., Maki K.C., Bays H., Carter R., and Ballantyne C.M. Effects of prescription omega-3-acid ethyl esters on lipoprotein particles in statin-treated subjects with hypertriglyceridemia. J Clin Lipidol (2009) [epub ahead of press, Sept. 2009]
27. De Luis D.A., Conde R., Aller R., Izaola O., González Sagrado M., Perez Castrillón J.L., et al. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. Eur Rev Med Pharmacol Sci 13 (2009) 51-55
28. Deveraj S., Hirany S.V., Burk R.F., and Jialal I. Divergence between LDL oxidative susceptibility and urinary F-2 isoprostanes as measure of oxidative stress in type 2 diabetes. Clin Chem 47 (2001) 1974-1979
29. Cao J., Schwichtenberg K.A., Hanson N.Q., and Tsai M.Y. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52 (2006) 2265-2272